Avid Bioservices Inc (CDMO)

[drragmop]

I think the possibility of developing some form of autoimmunity or loss of immune tolerance, or other immune-system complication, cannot be ruled out until larger numbers of humans receive the drug and are monitored for several to many months afterward. IMO, lack of a definitive showing of "no problem" is the main reason the stock is still somewhat risky.